Tavros Therapeutics and OpenBench Expand Strategic Collaboration for Small Molecule Drug Discovery

Posted on | by Allen Pajar

Multi-target collaboration leverages Tavros’ proprietary functional genomic discovery program and OpenBench’s screening platform